Keyphrases
Spironolactone
100%
Hepatic Insulin Resistance
100%
Cellular Networks
100%
Fatty Liver
66%
Metabolic Syndrome
66%
Non-alcoholic Fatty Liver Disease (NAFLD)
33%
Induced Phenotype
33%
Mouse Model
33%
%Fat
33%
Diet-induced Diabetes
33%
Insulin Resistance
33%
Hypertension
33%
Therapeutic Approaches
33%
Fructose
33%
Control Diet
33%
Diet-induced
33%
Lipid Metabolism
33%
Feed Control
33%
C57BL
33%
Glucose Metabolism
33%
Dyslipidemia
33%
Medicine and Dentistry
Insulin Resistance
100%
Spironolactone
100%
Metabolic Syndrome
66%
Fatty Liver
66%
Glucose Metabolism
33%
Nonalcoholic Fatty Liver
33%
Fructose
33%
C57BL/6
33%
Diabetes
33%
Dyslipidemia
33%
Lipid Metabolism
33%
High Fat Food
33%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Spironolactone
100%
Metabolic Syndrome X
66%
Fatty Liver
66%
Fructose
33%
Nonalcoholic Fatty Liver
33%
Mouse Model
33%
C57BL 6 Mouse
33%
Dyslipidemia
33%